Associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis

…, L Geys, T Parciak, C Gautrais, N Lazovski… - Neurology, 2021 - AAN Enterprises
Background and Objectives People with multiple sclerosis (MS) are a vulnerable group for
severe coronavirus disease 2019 (COVID-19), particularly those taking immunosuppressive …

COVID-19 in people with multiple sclerosis: a global data sharing initiative

…, L McKenna, N Lazovski… - Multiple Sclerosis …, 2020 - journals.sagepub.com
Background: We need high-quality data to assess the determinants for COVID-19 severity in
people with MS (PwMS). Several studies have recently emerged but there is great benefit in …

[HTML][HTML] Insights from the IronTract challenge: Optimal methods for mapping brain pathways from multi-shell diffusion MRI

…, JP Thiran, G Dai, G Grisot, N Lazovski… - NeuroImage, 2022 - Elsevier
Limitations in the accuracy of brain pathways reconstructed by diffusion MRI (dMRI) tractography
have received considerable attention. While the technical advances spearheaded by …

New insights from the IronTract challenge: Simple post-processing enhances the accuracy of diffusion tractography

…, G Grisot, S Puch, M Ramos, N Lazovski… - 2021 ISMRM & SMRT …, 2021 - orbit.dtu.dk
We present results from round 2 of IronTract, the first challenge to evaluate the accuracy of
tractography using i) tracer injections and diffusion MRI from the same macaque brains, and ii…

The IronTract challenge: Validation and optimal tractography methods for the HCP diffusion acquisition scheme

…, JP Thiran, G Dai, G Grisot, N Lazovski… - Proc. Intl. Soc. Mag …, 2020 - archive.ismrm.org
We present results from IronTract, the first challenge to evaluate tractography on the two-shell
diffusion scheme of the Human Connectome Project (HCP). Accuracy was evaluated by …

1298Associations of DMT therapies with COVID-19 severity in multiple sclerosis.

…, T Parciak, C Gautrais, N Lazovski… - International …, 2021 - search.ebscohost.com
Background People with multiple sclerosis (MS) are a vulnerable group for severe COVID-19,
particularly those taking immunosuppressive disease-modifying therapies (DMTs). We …

[PDF][PDF] Transposition of Subclavian Artery–Is It the Appropriate Choice?

N Lazovski, S Jovev, D Babic, S Babic, O Dzemali - prilozi, 2017 - sciendo.com
Introduction: To present patients with symptomatic subclavian artery disease and treatment
possibility. Case report: A 53-year-old female was admitted with vertigo and left arm …

[HTML][HTML] Optimal coronary artery bypass graft timing in high-risk acute myocardial infarction with ST elevation

J Sasko, M Slavica, D Suzana, L Nikola… - … Open Medical Journal, 2017 - cyberleninka.ru
Background Despite advances in surgical techniques, still tendency for waiting up to 6
weeks after myocardial infarction with ST segment elevation (STEMI). We aimed to evaluate …

[HTML][HTML] Associations of DMT therapies with COVID-19 severity in multiple sclerosis: an international cohort study

…, T Spelman, L Geys, T Parciak, C Gautrais, N Lazovski… - 2020 - europepmc.org
Background: People with multiple sclerosis (MS) may be a vulnerable group for severe
COVID-19, particularly those taking immunosuppressive disease-modifying therapies (DMTs). …

Urgent Endovascular Treatment of Iliac Artery Pseudoaneurysm in Patient with Ehlers-Danlos Syndrome: A Case Report

…, I Jovanoska, G Dungevski, N Lazovski… - … Macedonian Journal of …, 2020 - oamjms.eu
BACKGROUND: Ehlers-Danlos syndrome (EDS) type IV is a heritable disorder of
connective tissue that is mainly associated with vascular maladies such as aneurysms, …